XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 41,399 $ 42,863
Interest and accounts receivable, net 1,979 1,803
Marketable investments 1,006 1,034
Other current assets 1,576 1,727
Total current assets 45,960 47,427
Finance receivables, net 188,278 181,553
Marketable investments 106 119
Cost method investment 3,491 3,491
Deferred tax asset, net 19,460 20,539
Warrant assets 2,878 3,419
Intangible assets, net 9,467 9,964
Goodwill 8,404 8,404
Property and equipment, net 5,991 5,779
Other non-current assets 1,915 1,970
Total assets 285,950 282,665
Current liabilities:    
Accounts payable and accrued liabilities 4,863 5,087
Revolving credit facility 8
Total current liabilities 4,863 5,095
Contingent consideration payable 8,530 8,530
Other non-current liabilities 1,758 1,804
Total liabilities 15,151 15,429
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,834,813 and 12,836,133 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 13 13
Additional paid-in capital 4,431,804 4,431,719
Accumulated deficit (4,161,018) (4,164,496)
Total stockholders’ equity 270,799 267,236
Total liabilities and stockholders’ equity $ 285,950 $ 282,665